December 10, 2021   |   Growth Equity News Healthcare

PetDx raises $62 million in Series B financing to scale adoption of its canine multi-cancer early detection blood test, OncoK9

Declaration is thrilled to help accelerate the adoption of PetDx’s non-invasive canine oncology test, which uses next generation sequencing for the early detection of many types of cancer in dogs with a simple blood draw.